Successful applicants are already offered highly competitive compensation packages. However, it is anticipated that forthcoming changes to tuition fees proposed by the UK Government will result in students incurring uncapped fees of up to £27,000 for a three-year undergraduate degree course (£9,000 per year).
As a result, GSK has taken the decision to reimburse 100% of uncapped tuition fees for all undergraduates recruited in the UK. These payments will be made upon the commencement of full employment and will be conditional on the employee remaining with the company for a minimum of two years.
Uncapped fees, which are subject to Parliamentary approval, are expected to come into effect from September 2012. The timeline for the introduction of this new measure by GSK will mirror the Government's timeline, and will be offered to students incurring uncapped fees commencing in September 2012.
These changes are being introduced as part of the company's ongoing efforts to attract, recruit and retain the best talent and reflect the changing environment in the UK for students. The company believes these measures will help ensure that GSK remains a highly desirable place for graduates to consider working upon leaving university.
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.